Full Text View
Tabular View
No Study Results Posted
Related Studies
Fluoxetine in Pediatric Body Dysmorphic Disorder
This study is currently recruiting participants.
Study NCT00245635   Information provided by Mount Sinai School of Medicine
First Received: October 26, 2005   Last Updated: December 4, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Body Dysmorphic Disorder
Additional conditions recognized in this trial
Disease
Hypochondriasis
More general conditions related to this trial
Mental Disorders
Pathologic Processes
Somatoform Disorders
Interventions listed in this trial
Fluoxetine
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Mount Sinai School of Medicine
Food and Drug Administration (FDA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services